Post Feed

SSSI in force for fluoxetine

14 Dec 2023

The Therapeutic Goods Administration advises a Serious Scarcity and Substitutable Medicine Instrument (SSSI) is in force for the ZACTIN TABS fluoxetine hydrochloride 20mg dispersible tablet.

The TGA has published a web alert about the SSSI, and has updated the ‘About the shortage of fluoxetine 20 mg dispersible tablets (Zactin Tabs) webpage’ to include information about the SSSI for patients, carers and health professionals.

The substitution currently has PBS subsidy arrangements for the 20mg capsule products, and the PBS website has been updated with this information. The PBS has also released a specific web statement regarding the PBS subsidy arrangements for fluoxetine SSSI.